Asset Details
Do you wish to reserve the book?
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Do you wish to request the book?
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2005
Overview
This review critically summarizes the neuropathology and genetics of schizophrenia, the relationship between them, and speculates on their functional convergence. The morphological correlates of schizophrenia are subtle, and range from a slight reduction in brain size to localized alterations in the morphology and molecular composition of specific neuronal, synaptic, and glial populations in the hippocampus, dorsolateral prefrontal cortex, and dorsal thalamus. These findings have fostered the view of schizophrenia as a disorder of connectivity and of the synapse. Although attractive, such concepts are vague, and differentiating primary events from epiphenomena has been difficult. A way forward is provided by the recent identification of several putative susceptibility genes (including neuregulin, dysbindin, COMT, DISC1, RGS4, GRM3, and G72). We discuss the evidence for these and other genes, along with what is known of their expression profiles and biological roles in brain and how these may be altered in schizophrenia. The evidence for several of the genes is now strong. However, for none, with the likely exception of COMT, has a causative allele or the mechanism by which it predisposes to schizophrenia been identified. Nevertheless, we speculate that the genes may all converge functionally upon schizophrenia risk via an influence upon synaptic plasticity and the development and stabilization of cortical microcircuitry. NMDA receptor-mediated glutamate transmission may be especially implicated, though there are also direct and indirect links to dopamine and GABA signalling. Hence, there is a correspondence between the putative roles of the genes at the molecular and synaptic levels and the existing understanding of the disorder at the neural systems level. Characterization of a core molecular pathway and a ‘genetic cytoarchitecture’ would be a profound advance in understanding schizophrenia, and may have equally significant therapeutic implications.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
Adult and adolescent clinical studies
/ Biological and medical sciences
/ Catechol O-Methyltransferase - genetics
/ Dopamine
/ Dystrophin-Associated Proteins
/ Genetic Predisposition to Disease - genetics
/ Genetics
/ Glutamic acid receptors (ionotropic)
/ Humans
/ Medicine
/ Mutation
/ N-Methyl-D-aspartic acid receptors
/ Psychology. Psychoanalysis. Psychiatry
/ Schizophrenia - physiopathology
/ Synapses
/ Thalamus
